NZ333514A - Oral pharmaceutical composition comprising a triazole antifungal compound - Google Patents

Oral pharmaceutical composition comprising a triazole antifungal compound

Info

Publication number
NZ333514A
NZ333514A NZ333514A NZ33351497A NZ333514A NZ 333514 A NZ333514 A NZ 333514A NZ 333514 A NZ333514 A NZ 333514A NZ 33351497 A NZ33351497 A NZ 33351497A NZ 333514 A NZ333514 A NZ 333514A
Authority
NZ
New Zealand
Prior art keywords
pharmaceutical composition
oral pharmaceutical
antifungal compound
triazole antifungal
triazole
Prior art date
Application number
NZ333514A
Other languages
English (en)
Inventor
Surendra A Sangekar
Winston A Vadino
Ping I Lee
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NZ333514A publication Critical patent/NZ333514A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NZ333514A 1996-06-28 1997-06-25 Oral pharmaceutical composition comprising a triazole antifungal compound NZ333514A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67243296A 1996-06-28 1996-06-28
PCT/US1997/010122 WO1998000116A1 (en) 1996-06-28 1997-06-25 Oral composition comprising a triazole antifungal compound

Publications (1)

Publication Number Publication Date
NZ333514A true NZ333514A (en) 2000-05-26

Family

ID=24698529

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ333514A NZ333514A (en) 1996-06-28 1997-06-25 Oral pharmaceutical composition comprising a triazole antifungal compound

Country Status (16)

Country Link
EP (1) EP0914100A1 (ja)
JP (1) JP2000514059A (ja)
KR (1) KR20000022294A (ja)
CN (1) CN1228693A (ja)
AU (1) AU731704B2 (ja)
BR (1) BR9710069A (ja)
CA (1) CA2258683C (ja)
CZ (1) CZ421498A3 (ja)
HU (1) HUP9903869A3 (ja)
IL (1) IL127780A0 (ja)
NO (1) NO986087L (ja)
NZ (1) NZ333514A (ja)
PL (1) PL330864A1 (ja)
SK (1) SK177598A3 (ja)
TR (1) TR199802718T2 (ja)
WO (1) WO1998000116A1 (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0969821T1 (en) * 1997-03-26 2003-10-31 Janssen Pharmaceutica N.V. Pellets having a core coated with an antifungal and a polymer
WO1999063971A1 (en) * 1998-06-11 1999-12-16 Em Industries, Inc. Micro-osmotic controlled drug delivery systems
BR9906712A (pt) * 1998-07-17 2000-10-10 Janssen Pharmaceutica Nv Péletes que apresentam um núcleo revestido com um antifúngico e um polìmero
ES2157731B1 (es) * 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
FR2795961B1 (fr) * 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
KR100694667B1 (ko) * 1999-12-08 2007-03-14 동아제약주식회사 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제
US6663897B2 (en) * 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same
EP1842532A3 (en) * 2001-02-06 2009-04-22 Stiefel Laboratories, Inc. Oral sparingly water-soluble antifungal formulations and methods of making the same
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
ITMI20031096A1 (it) * 2003-05-30 2004-11-30 Eurand Spa Microcapsule per coacervazione contenenti farmaco incorporato nel polimero di rivestimento
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
CN105949278B (zh) * 2016-03-30 2019-12-06 南京曼杰生物科技有限公司 一种取代的四氢呋喃水溶性衍生物及其应用
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
CZ294823B6 (cs) * 1993-12-21 2005-03-16 Schering Corporation Fungicidní tetrahydrofurany

Also Published As

Publication number Publication date
CA2258683A1 (en) 1998-01-08
NO986087L (no) 1999-02-26
CN1228693A (zh) 1999-09-15
PL330864A1 (en) 1999-06-07
BR9710069A (pt) 1999-08-10
HUP9903869A3 (en) 2000-07-28
EP0914100A1 (en) 1999-05-12
HUP9903869A2 (hu) 2000-06-28
JP2000514059A (ja) 2000-10-24
NO986087D0 (no) 1998-12-23
AU3387497A (en) 1998-01-21
AU731704B2 (en) 2001-04-05
IL127780A0 (en) 1999-10-28
CZ421498A3 (cs) 1999-06-16
CA2258683C (en) 2007-07-31
WO1998000116A1 (en) 1998-01-08
SK177598A3 (en) 1999-07-12
KR20000022294A (ko) 2000-04-25
TR199802718T2 (xx) 1999-03-22

Similar Documents

Publication Publication Date Title
NZ333514A (en) Oral pharmaceutical composition comprising a triazole antifungal compound
EP1193270A3 (en) Pyrrolobenzodiazepines
AU3886195A (en) Thermally-protective intumescent coating
AU3484995A (en) Powder coating composition
DE69631790D1 (de) Pulverlackzusammensetzung
NO943452D0 (no) Bindemiddelblanding for pulverbelegg
AU7827191A (en) Sprayable fireproofing composition
AU6815090A (en) Repositionable adhesive tape
AU2210599A (en) Masking tape
AU1383699A (en) Coating composition
AU3668695A (en) Coating composition
AU9494898A (en) Powder coating composition
AU6935498A (en) Novel phosphate compounds and their use as medicaments
AU3457089A (en) Sprayable fireproofing composition
DE69310740T2 (de) Pulverbeschichtungszusammensetzung
AU3842693A (en) Coating compositions
DE69509440T2 (de) Pulverlack
AU2344095A (en) Benzamide derivative, compositions containing said derivative and use thereof
AU1133795A (en) Coating composition
EP0733691A3 (de) Schmelzklebermasse zur Beschichtung von Einlagenstoff
DE69515406T2 (de) Pulverlack-Bindemittel-Zusammensetzung
DE69510593D1 (de) Pulverbeschichtung
AUPM981994A0 (en) Magnetic coating composition
AU5882298A (en) New analgesic composition
AU7310191A (en) Photoluminescent materials, particularly for coating various surfaces, and uses thereof